FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095464 [Registered on: 30/09/2025] Trial Registered Prospectively
Last Modified On: 29/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Single Arm Study 
Public Title of Study   Improving influenza management practices 
Scientific Title of Study   Improving Influenza Management and Prevention Practices among Physicians and vaccine uptake in high-risk groups at selected cities of India 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aftab Ahmad 
Designation  PhD Scholar 
Affiliation  All India Institute of Medical Sciences New Delhi 
Address  Room No 13 Centre for Community Medicine
All India Institute of Medical Sciences Ansari Nagar E
South
DELHI
110029
India 
Phone  9471391789  
Fax    
Email  aftab.ind@gmail.com  
 
Details of Contact Person
Scientific Query  
Name  Anand Krishnan 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences New Delhi 
Address  Room No 13 Centre for Community Medicine
All India Institute of Medical Sciences Ansari Nagar E
South
DELHI
110029
India 
Phone  9811500667  
Fax    
Email  anand.drk@gmail.com  
 
Details of Contact Person
Public Query  
Name  Anand Krishnan 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences New Delhi 
Address  Room No 13 Centre for Community Medicine
All India Institute of Medical Sciences Ansari Nagar E

DELHI
110029
India 
Phone  9811500667  
Fax    
Email  anand.drk@gmail.com  
 
Source of Monetary or Material Support  
Centre for Community Medicine All India Institute of Medical Sciences, New Delhi, India - 110029 
 
Primary Sponsor  
Name  Dr Anand Krishnan 
Address  Professor of Centre for Community Medicine All India Institute of Medical Sciences New Delhi India 110029 
Type of Sponsor  Other [Individual Sponsor Guide] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aftab Ahmad  All india Institute of Medical Sciences  Room No 13 Centre for Community Medicine All India Institute of Medical Sciences Ansari Nagar (E)
South
DELHI 		 9471391789

aftab.ind@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Insitutional Ethics Committee All India Institute of Medical Sciences New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Physicians involved in influenza management 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Educational Intervention  Self Directed Learning Intervention which would be in the form of a 2 hour online training for physicians 
Comparator Agent  NA  NA 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Physicians working in the departments of General Medicine, Pulmonology / TB Chest Department, Pediatrics Department, Obstetrics and Gynecology department and Geriatrics department in the selected hospital
2. The minimum qualification of the physician should be MBBS.
 
 
ExclusionCriteria 
Details  Physicians of alternative systems of medicine like AYUSH. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Adherence to diagnostic guidelines (e.g., use of RT-PCR for SARI patients), therapeutic practices (e.g., prescription of antivirals for influenza-confirmed SARI cases), and vaccination practices (e.g., recommending and administering influenza vaccines to high-risk groups).  Pre intervention, post intervention and 6 months post intervention 
 
Secondary Outcome  
Outcome  TimePoints 
1. Proportion of physicians from each department who undertake the intervention – This will provide insights into the acceptance and uptake of the educational module across different specialties.
2. Percent increase in knowledge and practice across three domains—diagnostics, therapeutics, and prevention – This will be evaluated using the difference in pre-test and post-test scores, which will be embedded within the training program. Improvements in these scores will reflect the intervention’s success in enhancing physicians’ understanding of influenza management.
 		 Pre intervention, post intervention and 6 months post intervention 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/10/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [aftab.ind@gmail.com].

  6. For how long will this data be available start date provided 01-01-2028 and end date provided 01-01-2031?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

A quasi-experimental pre-post intervention design will be employed in the same four cities. Physicians from the institutions involved in Objective 1 will be invited to participate in a self-directed educational intervention comprising six video modules (total ~2 hours) aligned with MoHFW guidelines. The modules will cover transmission, diagnosis, treatment, and prevention of influenza, and will be hosted online. Pre- and post-test assessments will be embedded within the platform, followed by a repeat survey at 6 months. Uptake and changes in knowledge and practices will be analyzed using generalized linear models with mixed effects, with stratified and sensitivity analyses for robustness. Per-protocol and intention-to-treat analyses will assess intervention impact.

 
Close